State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
J Mater Chem B. 2020 Jun 7;8(21):4609-4619. doi: 10.1039/d0tb00070a. Epub 2020 May 6.
Tumor phototherapy is of great significance for the expansion and advancement of cancer treatment methods. Herein, two-dimensional boron nanosheets (B NSs) with a thickness of 2.4 nm exhibiting an excellent photothermal conversion performance were developed via a simple liquid phase ultrasonic stripping method. Following the loading of the photosensitizer agent chlorin e6 (Ce6) and subsequent modification with poly(allylamine hydrochloride) (PAH) and poly(acrylic acid) (PAA), a B@Ce6-PAH-PAA NS nanomedicine exhibiting dual modal imaging-guided cancer photothermal therapy (PTT) and photodynamic therapy (PDT) properties, as well as outstanding stability was developed. The suitable nano-size (120 nm) of B@Ce6-PAH-PAA NSs can allow drugs to target tumor tissue with an enhanced permeability and retention effect (EPR). The cytotoxicity experiments demonstrated that B@Ce6-PAH-PAA NSs exhibited good biocompatibility even at high concentrations. Furthermore, the in vitro and in vivo experiments showed the excellent synergistic therapeutic effect of this nanomedicine for PTT and PDT.
肿瘤光疗对于癌症治疗方法的扩展和进步具有重要意义。在此,通过简单的液相超声剥离法开发了厚度为 2.4nm 的二维硼纳米片(B NSs),其具有优异的光热转换性能。随后负载光敏剂氯代叶绿素 e6(Ce6),并进一步用聚(烯丙基胺盐酸盐)(PAH)和聚(丙烯酸)(PAA)修饰,得到了一种具有双模态成像引导癌症光热治疗(PTT)和光动力治疗(PDT)特性以及出色稳定性的 B@Ce6-PAH-PAA NS 纳米药物。B@Ce6-PAH-PAA NSs 的合适纳米尺寸(120nm)可使药物以增强的通透性和保留效应(EPR)靶向肿瘤组织。细胞毒性实验表明,B@Ce6-PAH-PAA NSs 即使在高浓度下也具有良好的生物相容性。此外,体外和体内实验表明,这种纳米药物对 PTT 和 PDT 的协同治疗效果优异。